| Publisher |
The Company of Biologists |
| Agreement ID | compbio2023julac |
| Agreement labeling | Read & Publish Agreement |
| Has the agreement been fully disclosed and published? | No |
| Agreement period | 01/01/2023 – 12/31/2025 |
| Consortia / Institution | JULAC |
| Country | Hong Kong |
| SIZE
Approximate range of annual corresponding author publications |
7 |
| COSTS
How do the costs of the agreement relate to previous subscription-only agreements with the publisher? |
Agreement costs within the range of the previous spending level |
| Comments on cost development | No previous consortia agreement |
| FINANCIAL SHIFT
Transformative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard? |
Subscriptions partly converted to OA publishing fees |
| RISK SHARING
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements? |
Unlimited free OA articles |
| OA COVERAGE
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement? |
Yes |
| Are fully open access journals covered by the agreement? | Yes |
| OA LICENSE | CC-BY mandatory |
| ARTICLE TYPES |
Original research articles |
| ACCESS COSTS
What is the approximate share of access related costs of the overall agreement? |
More than 50% |
| ACCESS COVERAGE
Are all read relevant journals covered by the agreement? |
Yes |
| PERPETUAL ACCESS RIGHTS | Yes |
| WORKFLOW ASSESSMENT | Too early to assess |
| Request contact to the licensee | contact [at] esac-initiative [dot] org |